Gene therapy is linked to better nonmotor outcomes in spinal muscular atrophy type 1 compared to first-line nusinersen, new ...

In a case that was billed as profits versus patients, India’s Supreme Court dismissed a petition in which Roche sought to ...

With this judgment, Natco Pharma can now sell the Spinal Muscular Atrophy treatment drug for ₹15,900 compared to the previous ...

Imagine a child born in a family with a rare disease, whose treatment would cost more than 17 crore for a single dose. The ...

The Supreme Court on Friday dismissed Swiss drugmaker Roche’s appeal challenging Delhi High Court orders that refused to ...

The parents of two boys born with a rare genetic disorder have demanded the rollout of a life-changing heel prick test – ...

Roche sued Natco in early 2024 after learning that the Hyderabad-based company plans to launch a lower-cost generic version ...

Nearly all children with spinal muscular atrophy who started on Evrysdi before symptom onset are walking after three years, ...

Biogen specializes in therapies for complex neurological and neurodegenerative conditions. With a diversified product suite ...

Supreme Court dismisses Roche's petition, allowing NATCO Pharma to sell affordable spinal muscular atrophy drug in India.

For people with spinal muscular atrophy, physical therapy can help support mobility, strength, and quality of life, regardless of SMA type.

AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) announced that the Phase 2a clinical result of AJ201 for spinal and bulbar ...